P-122

泼尼松 溶液

100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant^®

• 經驗公式（希爾表示法）: C₂₁H₂₆O₅
• CAS號碼: 53-03-2
• 分子量：: 358.43
• MDL號碼: MFCD00003608
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329820080
• NACRES: NA.24

屬性

• 等級: certified reference material
• 品質等級: 300
• 形狀: liquid
• 特點: Snap-N-Spike^®/Snap-N-Shoot^®
• 包裝: ampule of 1 mL
• 製造商／商標名: Cerilliant^®
• 濃度: 100 μg/mL in acetonitrile
• 技術: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• mp: -48 °C
• 密度: 0.78 g/cm³ at 20 °C
• 應用: clinical testing
• 格式: single component solution
• 儲存溫度: −20°C
• InChI: 1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1
• InChI 密鑰: XOFYZVNMUHMLCC-ZPOLXVRWSA-N
• 基因資訊: human ... NR3C1(2908)

描述

一般說明

用于基于质谱的临床测试应用中校准或鉴定生物样品中泼尼松的校准标准品和质控品，包括治疗药物监测、内分泌学、癌症治疗和确认继发性肾上腺功能不全的原因。泼尼松是一种合成的皮质类固醇药物，用于治疗多种炎症性疾病和病症。

應用

• A Breath of Relief: Oxymetazoline and Flunisolide Nasal Spray in the Management of Myasthenia Gravis Ptosis.: This study explores the use of corticosteroid solutions, like Prednisone, in managing inflammatory conditions. Prednisone solution is essential for understanding its anti-inflammatory effects in clinical settings and can be applied in biochemistry and cell signaling studies (Aloyan et al., 2024).


• Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.: Prednisone solution is highlighted for its role in achieving remission and low disease activity in autoimmune diseases like lupus, emphasizing its importance in laboratory and clinical research for autoimmune and inflammatory conditions (Barber et al., 2024).


• Freeze-dried amniotic membrane graft with a spongy layer in bilateral peripheral ulcerative keratitis: a case report.: This case report discusses the application of Prednisone solution in treating severe inflammatory eye conditions, demonstrating its use in autoimmune disease and inflammatory response research (Bertret et al., 2023).


• 2023 Canadian Thoracic Society Guideline on Pharmacotherapy in Patients With Stable COPD.: Prednisone solution is part of the pharmacotherapy guidelines for managing chronic inflammatory respiratory conditions like COPD, showcasing its relevance in asthma treatment and biochemistry studies focused on respiratory inflammation (Bourbeau et al., 2023).


• Retrospective Analysis With Propensity Score Matching of Peripheral T-Cell Lymphoma Treated Frontline With Brentuximab Vedotin and Chemotherapy.: This research highlights the role of Prednisone solution in oncology, specifically in managing inflammatory responses during cancer treatment, making it crucial for pharmacological experimentation in cancer and inflammation research (Burke et al., 2023).

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 象形圖: GHS02,GHS07
• 訊號詞: Danger
• 危險聲明: H225,H302 + H312 + H332,H319
• 防範說明: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338
• 危險分類: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: 35.6 °F - closed cup
• 閃點（°C）: 2.0 °C - closed cup